Mu Yuan

机构：Center for Drug Evaluation and Research, Guizhou Normal University, Drug Safety Research Unit, ZheJiang Institute For Food and Drug Control · ORCID：0000-0002-1814-8922

发表论文 66 篇 · 总被引 555 次 · h-index 12

代表论文

• Development of an artificial intelligence based model for predicting the euploidy of blastocysts in PGT-A treatments (2023 · Scientific Reports · 被引 31)
• Occupational stress, respect, and the need for psychological counselling in Chinese nurses: a nationwide cross-sectional study (2023 · Public Health · 被引 15)
• Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates (2023 · Journal of Inflammation Research · 被引 12)
• DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity (2025 · Cell Reports · 被引 7)
• Combination of donafenib and anti-PD-1 antibody plus trans-arterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (uHCC). (2022 · Journal of Clinical Oncology · 被引 6)
• Examining the dietary contributions of lipids to pancreatic cancer burden (1990–2021): incidence trends and future projections (2025 · Lipids in Health and Disease · 被引 5)